2021
DOI: 10.1039/d0fo03479g
|View full text |Cite
|
Sign up to set email alerts
|

Lactobacillus rhamnosusfrom human breast milk ameliorates ulcerative colitis in miceviagut microbiota modulation

Abstract: L. rhamnosus SHA113 (LRS) relieves ulcerative colitis (UC) via the regulation of gut microbiota.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

8
32
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 37 publications
(41 citation statements)
references
References 68 publications
8
32
1
Order By: Relevance
“…Here, DSS treatment also changed the composition of the bacteria community in comparison with the control group; we reviewed the literature and found that it is a common phenomenon. [ 7,46,47 ] It is understandable because DSS may somehow affect the bacteria community, and on the other hand, colitis is always accompanied by microbiota alteration. [ 48 ] The general enterobacteria composition of each sample at the phylum and family level (Figure 5c,d) was shown by bar chart and heatmap, respectively.…”
Section: Resultsmentioning
confidence: 99%
“…Here, DSS treatment also changed the composition of the bacteria community in comparison with the control group; we reviewed the literature and found that it is a common phenomenon. [ 7,46,47 ] It is understandable because DSS may somehow affect the bacteria community, and on the other hand, colitis is always accompanied by microbiota alteration. [ 48 ] The general enterobacteria composition of each sample at the phylum and family level (Figure 5c,d) was shown by bar chart and heatmap, respectively.…”
Section: Resultsmentioning
confidence: 99%
“…20 In general, the UC-attenuating effects of probiotics are mainly due to (1) preventing the colonization of pathogenic bacteria via competing for common receptors or nutrients and (2) inhibiting the growth of pathogenic bacteria by producing organic acid, bacteriocin, or antitoxin proteases, so as to modulate intestinal microbiota, enhance the gut barrier function, regulate metabolism, or suppress inflammation. 19,21 Nevertheless, the clinical application of probiotics to ameliorate UC is still limited because the species-specific effects of probiotics may cause different clinical effects. Therefore, it is necessary to explore some new probiotics with UC-ameliorating effects and study their mechanisms.…”
Section: ■ Introductionmentioning
confidence: 99%
“…
Ulcerative colitis (UC), belonging to chronic inflammatory bowel disease (IBD), has increasing morbidity (Pang et al, 2021), especially in the developing countries (Nascimento et al, 2020). UC is a frequently-occurring disease between the age of 30 and 40 (Armuzzi & Liguori, 2021) and is characterized by a long disease course and repeated attacks.
…”
mentioning
confidence: 99%